Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
-
FG Nexus to Present at the 2025 Cantor Crypto & AI/Energy Infrastructure Conference
-
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
-
IMUNON R&D Day Showcases Clinical Progress of Its Novel Immunotherapy, Phase 3 Trial and Significant Potential for Women with Ovarian Cancer
-
Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Matador Technologies Inc. Announces Closing of Convertible Note Facility to Expand Bitcoin Holdings
-
Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments
-
Vera Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
-
Vera Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
-
Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System
-
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
-
Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History
-
Wenlay Releases Cross-Chain Bridge Solution to Tackle Multi-Chain Liquidity Challenges
-
Exodus Movement, Inc. Announces Acquisition of Grateful To Strengthen Stablecoin-Based Payments
-
Alpha Modus Secures Patent License and Expands AI-Retail Ecosystem Through New Authorized Reseller Agreement
-
AirBoss Defense Group Received Order CBRN Products Valued at $8.1M
-
Genmab Announces Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes and Syndication of New Senior Secured Term Loan Facility
-
Same-Day Loans with Guaranteed Approval and No Credit Check for Bad Credit Borrowers: Introduced by RadCred for Debt Relief
-
Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results
-
uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update
-
Outdoor Holding Company Reports Positive Net Income from Continuing Operations for Second Quarter Fiscal 2026
-
VALLOUREC ANNOUNCES EXPANSION OF YOUNGSTOWN MANUFACTURING OPERATIONS
-
Cielo Announces Closing of First Tranche of Unit Offering
-
MAX Power Brings Together Leading Natural Hydrogen Experts for Technical Collaboration and Drill Site Visit
-
Kaspi.kz 3Q & 9M 2025 Financial Results
-
Orbus Therapeutics Announces Oral Presentation of Updated Results With Blinded Independent Central Review from the Phase 3 STELLAR Clinical Trial at the Society for Neuro-Oncology Annual Meeting
-
Enviri Corporation Reports Third Quarter 2025 Results
-
Zacatecas Silver Secures Community Access Agreement at Panuco and Signs Drill Contract with Major Drilling
-
Norwegian Cruise Line Holdings Confirms Newbuild Order for Third Prestige-Class Ship for Regent Seven Seas Cruises
-
ONL Therapeutics to Present at EYENOVATE and the FLORetina–ICOOR Congress 2025
-
Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025
-
Anfield Energy Welcomes U.S. Designation of Uranium as Critical Mineral, Unlocking Funding and Accelerated Development for Domestic Projects
-
Apogee Therapeutics Announces Positive Interim Phase 1 Results from Healthy Volunteer Trial of APG333, its Novel Half-Life Extended TSLP Antibody
-
Electra Moves Cobalt Refinery Build Forward with Major Construction Tender
-
Galecto Announces Acquisition of Damora Therapeutics
-
Atana Unveils Organizational Insights to Close Learning Gaps and Reduce Risk Through Strategic Intelligence
-
Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth
-
Nurix Therapeutics Appoints Accomplished Biopharmaceutical Leader Roger Dansey, M.D., to Its Board of Directors
-
Akebia Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Perma-Fix Reports Financial Results and Provides Business Update for the Third Quarter of 2025
-
CervoMed Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
-
Tecnoglass to Attend the Baird 2025 Global Industrial Conference
-
Osisko Development Reports Third Quarter 2025 Results
-
Lifeward to Report Third Quarter Financial Results on November 14, 2025
-
Cogent Biosciences Reports Positive Results from Bezuclastinib PEAK Phase 3 Trial in Gastrointestinal Stromal Tumors (GIST)
-
Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Atlético de Madrid to Welcome Apollo Sports Capital as Majority Shareholder
-
Tower Semiconductor Reports Third Quarter 2025 Financial Results
-
Cullinan Therapeutics to Participate in Upcoming Investor Conferences and Host Analyst and Investor Event at 2025 ASH Annual Meeting
-
TEGNA Inc. Reports Third Quarter 2025 Results
